Complete your ObesityWeek Evaluations

Join the conversation

Session Agenda

T-3027-OR: Additional Analyses of the Weight-Lowering Efficacy of Liraglutide 3.0 mg in Overweight and Obese Adults: The SCALE Obesity and Prediabetes Randomized Trial - Frank L. Greenway, MD; Carel W. le Roux, FRCP, FRCPath, PhD; David CW. Lau, MD, PhD, FRCPC; Arne Astrup, MD, DMSc; Ken Fujioka, MD; Alfredo Halpern, MD; Michel Krempf, PhD; Rafael Violante Ortiz, MD; John Wilding, DM FRCP; Claus B. Svendsen, MD, PhD; Christine Bjoern B. Jensen, MD PhD; Xavier Pi-Sunyer, MD, MPH
T-3028-OR: Early Effects of Lorcaserin (LOR) on Glycemic Parameters in Obese and Overweight Patients (pts) with Type 2 Diabetes Mellitus (T2D): A Retrospective Analysis of BLOOM-DM - Elisa Fabbrini, MD PhD; Randi Fain, MD; Alan Glicklich, MD, MBA; Yuhan Li, MS; William Shanahan, MD; William Soliman, PhD
T-3029-OR: Variable Weight Loss Resulting from Individual Responses to Short-Term Fasting and Overfeeding - Martin Reinhardt, MD; Marie S. Thearle, MD; Mostafa Ibrahim, BS; Maximilian G. Hohenadel, MD; Jonathan Krakoff, MD; Susanne B. Votruba, PhD, RD
T-3030-OR: Weight Loss with Liraglutide 3.0 mg Is Associated with Improved Health-Related Quality of Life (HRQoL) and Treatment Satisfaction in Overweight or Obese Adults with Type 2 Diabetes (T2D): The SCALE Diabetes Randomized, Double-Blind, Placebo-Controlled 56-week Trial - Robert F. Kushner, MD, FTOS; Bruce Bode, MD; Andrew Lewin, MD; Trine V. Skjøth, MD; Christine Bjoern B. Jensen, MD PhD; Ralph DeFronzo, MD; Melanie Davies, MB ChB, MRCP, MD, FRCP
T-3031-OR: Liraglutide 3.0 mg Reduces Body Weight and Improves Health-Related Quality of Life (HRQoL) in Overweight or Obese Adults without Diabetes: the SCALE Obesity and Prediabetes Randomized, Double-Blind, Placebo-Controlled, 56-week Trial - Ken Fujioka, MD; Arne Astrup, MD, DMSc; Frank L. Greenway, MD; Alfredo Halpern, MD; Michel Krempf, PhD; David CW. Lau, MD, PhD, FRCPC; Carel W. le Roux, FRCP, FRCPath, PhD; Rafael Violante Ortiz, MD; John Wilding, DM FRCP; Michael L. Wolden, Msc; Christine Bjoern B. Jensen, MD PhD; Xavier Pi-Sunyer, MD, MPH
T-3032-OR: Evidence of Metabolic Adaptation after 2 Years of 25% Calorie Restriction in Non-Obese Humans - Leanne M. Redman, PhD; Steven R. Smith, MD, FTOS; Vishwa Dixit, Ph.D.; Eric Ravussin, PhD